Specialty Pharmacy

Thus far there is no intervention that clearly reduces the risk of HCV infection from a mother to her child.

Olaparib (Lynparza) is indicated to treat HER2-negative metastatic breast cancer with BRCA mutations.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about data analytics and specialty pharmacy.

Myeloablative autologous hematopoietic stem cell transplant may provide long-term benefits for patients with scleroderma.

A high concentration of Americans with hepatitis C virus are incarcerated.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

ART was associated with lower rates of high-risk human papillomavirus and invasive cervical cancer among women with HIV.

Show us how you are celebrating National Pharmacist Day by using #APharmacistIs on social media.

Investigational immunotherapy combination may benefit patients with unresectable kidney cancer.

Denosumab (Xgeva) demonstrated non-inferiority to zoledronic acid in patients with multiple myeloma.

Advancing biomarker research may help determine which patients with non-invasive breast cancer will develop invasive disease.

Novel gene therapy technique may lead to a long-term therapy against HIV.

Top news of the day from across the health care landscape.

Ribavirin steady-state serum levels correspond to high rates of efficacy and low adverse effect from direct-acting antiviral drugs for difficult-to-treat hepatitis C virus.

Matt Gillin, Chief Executive Officer, Relay Network, discusses what a crucial role technology plays in medication adherence.

New legislation would remove rules that prevent pharmacists from telling patients their prescriptions would be cheaper without insurance.

Eating processed meats may escalate breast cancer risk above 20%.

Cancer may slow down protein synthesis and alter circadian rhythm to avoid cell death.

A panel of multiple sclerosis experts recently modified the 2010 McDonald Criteria to improve the diagnostic process.

The opioid epidemic has led to an increase in HCV-positive liver donations.

Top news of the day from across the health care landscape.

Landmark trial to evaluate the superiority of secukinumab for slowing spinal bone damage versus proposed biosimilar adalimumab.

Electronic prior authorization can reduce time to fill for specialty drugs.

Estrogen produced during pregnancy could reduce multiple sclerosis relapses by 70%.

Blueberries may act as a radiosensitizer that could reduce damage to healthy cells caused by traditional cancer treatments.

Implementing a one-time screening for HIV at age 25 may be a cost-effective way to identify new infections.

Top news of the day from across the health care landscape.

The path to a hepatitis C vaccine is yielded by the virus’ virulent nature and its evasiveness to immune responses.